Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eco Animal Health GroupFRA:LWA -0.91%52 Equity-to-Asset is 0.74 as of Mar. 2026, which is 1% above its 10-year median of 0.73. GuruFocus rates FRA:LWA with a GF Score™ of 52/100 and a GF Value™ of €1.11. The stock has 3 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Eco Animal Health Group ranks better than 71.17% on this metric.
Eco Animal Health Group (FRA:LWA) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Eco Animal Health Group Equity-to-Asset Related Terms
Eco Animal Health Group Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:LWA vs ZTS, UTHR, VTRS: Equity-to-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eco Animal Health Group Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Eco Animal Health Group's Equity-to-Asset falls into.
Eco Animal Health Group Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Eco Animal Health Group's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eco Animal Health Group (FRA:LWA) has a Equity-to-Asset of 0.74 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Eco Animal Health Group and its competitors. This is near median its historical median of 0.73. Over the past decade, Eco Animal Health Group's Equity-to-Asset has ranged from 0.68 to 0.83. According to the industry distribution chart, Eco Animal Health Group ranks #290 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 28.8%.
Is Eco Animal Health Group's Equity-to-Asset too high?
Eco Animal Health Group's current Equity-to-Asset of 0.74 is near median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.68 to a high of 0.83. The Drug Manufacturers industry median Equity-to-Asset is 0.60. Eco Animal Health Group's value of 0.74 is 23.3% above this industry median. Based on the distribution chart, Eco Animal Health Group ranks #290 out of 1006 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Eco Animal Health Group has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Eco Animal Health Group's Equity-to-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Eco Animal Health Group ranks #290 out of 1006 companies for Equity-to-Asset. This puts Eco Animal Health Group in the upper half of its industry. The industry median Equity-to-Asset is 0.60. Eco Animal Health Group's value of 0.74 is 23.3% above this benchmark. Historically, Eco Animal Health Group's own Equity-to-Asset has ranged from 0.68 to 0.83 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 0.60, Eco Animal Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eco Animal Health Group's current Equity-to-Asset of 0.74 is 23.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Eco Animal Health Group and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eco Animal Health Group's current Equity-to-Asset is 0.74, which is near median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eco Animal Health Group stock overvalued right now?
Eco Animal Health Group (FRA:LWA) has a current Equity-to-Asset of 0.74. The stock's GF Value™ is €1.11, compared to a current price of €1.09 — trading 1.8% below its estimated fair value. The current Equity-to-Asset is 0.74, which is near median its 10-year median of 0.73 and 23.3% above the Drug Manufacturers industry median of 0.60. Eco Animal Health Group's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Eco Animal Health Group (FRA:LWA), the current Equity-to-Asset is 0.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eco Animal Health Group (FRA:LWA) Overvalued in 2026?
Based on GuruFocus' analysis, Eco Animal Health Group stock appears to be undervalued.
The current stock price of €1.09 is trading 1.8% below its estimated GF Value™ of €1.11.
Key valuation signals for FRA:LWA:
Equity-to-Asset: 0.74 (near median its 10-year median of 0.73)
GF Value™: €1.11 vs. price of €1.09 (1.8% below fair value)
Industry Position: 23.3% above the Drug Manufacturers median (#290 of 1006)
No single metric tells the full story. See the FRA:LWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eco Animal Health Group PLC is an animal health biotech company. It provides quality products for swine and poultry, anti-infectives to treat illness, improve health, and performance. Its products include Aivlosin/Valosin Solutions and Parasite Solutions. The company's segments include Corporate/UK, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World, with the majority of the revenue deriving from China and Japan.
52GF Score
Get the complete analysis for FRA:LWA
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LWA has been successfully added to your 
